Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

Schizophrenia Research
P Roberto BakkerJ van Os

Abstract

A polymorphic site in the gene encoding the dopamine 3 receptor (DRD3) resulting in a serine (Ser) into glycine (Gly) substitution has been shown to affect dopamine binding affinity, and may contribute to individual differences in susceptibility to antipsychotic-induced tardive dyskinesia (TD). A Medline, EMBASE and PsychINFO search of literature published between 1976 and March 2005 yielded 11 studies from which data were extracted for calculation of pooled estimates using meta-analytic techniques. The Gly allele increased the risk relative to the Ser allele (OR=1.17; 95% CI: 1.01-1.37) with evidence of publication bias. No significant genotype effects were apparent. TD may be associated with functional variation in the DRD3 allele. However, caution is required in interpreting this finding, as there is evidence of publication bias, genetic methodology has shortcomings, and the relation between antipsychotics, schizophrenia and TD is complex.

References

Jan 1, 1992·Schizophrenia Bulletin·R Yassa, D V Jeste
Sep 1, 1995·Archives of General Psychiatry·D V JesteL A McAdams
Jan 1, 1994·Hospital & Community Psychiatry·W M GlazerJ Doucette
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·D AcciliS Fuchs
Sep 20, 1997·Acta Psychiatrica Scandinavica·J van OsR Murray
Feb 25, 1998·Brain Research·M SuzukiG Sedvall
Apr 18, 1998·The American Journal of Psychiatry·Peter N van HartenR S Kahn
Jun 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·V BasileJames L Kennedy
Mar 30, 2000·European Archives of Psychiatry and Clinical Neuroscience·Marcella RietschelM M Nöthen
Nov 10, 2000·Pharmacopsychiatry·M Marsálek
May 10, 2001·The International Journal of Neuropsychopharmacology·Roger LøvlieVidar M Steen
Aug 2, 2001·Journal of Neural Transmission·M M Garcia-BarcelóW K Tang
Nov 28, 2001·Acta Psychiatrica Scandinavica·Daniel J MüllerMarcella Rietschel
Jun 14, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B LererFabio Macciardi
Sep 28, 2002·Human Molecular Genetics·V BasileJames L Kennedy
Oct 9, 2002·The International Journal of Neuropsychopharmacology·Bernard Lerer, Fabio Macciardi
Dec 24, 2002·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Siow-Ann ChongYiong Huak Chan
Jul 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Robin G McCreadieRamachandra Padmavathi
Mar 26, 2004·The Pharmacogenomics Journal·Daniel J MüllerJames L Kennedy
Sep 24, 2004·The International Journal of Neuropsychopharmacology·Enrico LattuadaEnrico Smeraldi
Dec 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Rebekka LencerChristine Klein
Jan 7, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Mechteld L C HoogendoornRichard J Sinke
Mar 1, 2005·The Psychiatric Clinics of North America·Perminder S Sachdev
Apr 30, 2005·Pharmacogenetics and Genomics·Nikolaos A PatsopoulosJohn P A Ioannidis

Citations

Jul 14, 2011·Psychopharmacology·Jeroen P KoningGenetic Risk and Outcome in Psychosis (GROUP) investigators
Dec 31, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·James J CrowleyPatrick F Sullivan
Aug 30, 2008·Schizophrenia Bulletin·Maria J Arranz, Shitij Kapur
Jan 22, 2009·European Journal of Human Genetics : EJHG·Anna C NeedDavid B Goldstein
Nov 17, 2010·The Pharmacogenomics Journal·James J CrowleyPatrick F Sullivan
Feb 9, 2012·Nature Reviews. Gastroenterology & Hepatology·M Camilleri
Jun 13, 2012·Journal of Clinical Gastroenterology·M Camilleri, Andrea Shin
Jul 26, 2008·Current Psychiatry Reports·Benedicto Crespo-FacorroIgnacio Mata
May 15, 2013·Journal of Molecular Neuroscience : MN·L GreenbaumB Lerer
Apr 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jiekun XuanLin He
Jun 10, 2009·The Pharmacogenomics Journal·P GassóA Lafuente
Aug 3, 2011·The Pharmacogenomics Journal·L GreenbaumB Lerer
Jan 28, 2010·Expert Opinion on Pharmacotherapy·Falk W Lohoff, Thomas N Ferraro
Dec 18, 2010·Expert Opinion on Drug Metabolism & Toxicology·Jian-Ping Zhang, Anil K Malhotra
Sep 14, 2010·Clinics in Laboratory Medicine·Peter P Zandi, Jennifer T Judy
Feb 18, 2010·The Psychiatric Clinics of North America·Peter P Zandi, Jennifer T Judy
May 15, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Asmar F Y Al HadithyAnton Jm Loonen
May 13, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tsutomu TakahashiNorio Ozaki
Apr 5, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Asmar F Y Al HadithyP N van Harten
May 2, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·I Omer BarlasOzcan Uzun
Apr 20, 2012·Journal of Psychiatric and Mental Health Nursing·S Mutsatsa, T J Currid
Aug 7, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·James T TeoKailash Bhatia
May 20, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Souha MahmoudiPierre J Blanchet
Jul 22, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Peter Jenner
Dec 21, 2013·British Journal of Clinical Pharmacology·Gavin P ReynoldsCaroline F Dalton
Aug 1, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Diederik E TenbackJ van Os
Apr 10, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Huei-Ting TsaiCharles Poole
Nov 6, 2009·Alimentary Pharmacology & Therapeutics·A S Rao, M Camilleri
Apr 4, 2007·The American Journal of Medicine·David B GoldsteinSanjay M Sisodiya
Apr 10, 2016·Perspectives in Psychiatric Care·Lillian Jan FindlayRif S El-Mallakh
Sep 9, 2006·The International Journal of Neuropsychopharmacology·Clement C ZaiJames L Kennedy
Jul 30, 2016·Pharmacogenomics·Rachel K LanningDaniel J Müller
Feb 17, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Clement C ZaiJames L Kennedy
Oct 1, 2016·Restorative Neurology and Neuroscience·Bo-Ram KimJongmin Lee
Mar 7, 2014·Journal of Psychopharmacology·Maju M KoolaKatherine J Aitchison
Oct 30, 2008·Journal of Psychopharmacology·A CaykoyluO Deniz
Mar 13, 2018·Current Opinion in Psychiatry·Clement C ZaiJames L Kennedy
Apr 18, 2018·The Cochrane Database of Systematic Reviews·Samer AlabedHanna Bergman
Jun 6, 2007·Molecular Psychiatry·Maria J Arranz, Jose de Leon
Feb 25, 2009·The Pharmacogenomics Journal·C C ZaiJames L Kennedy
Oct 16, 2009·Psychiatric Genetics·Ismail Al-JanabiJose de Leon
Dec 17, 2009·Psychiatric Genetics·Gabriela NovakBernard Le Foll
Jun 8, 2010·Therapeutic Drug Monitoring·Werner Steimer
Aug 13, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Emmanouil RizosLefteris P Lykouras
Nov 26, 2011·Expert Review of Clinical Pharmacology·Maria J Arranz, Janet C Munro
Jul 23, 2020·G3 : Genes - Genomes - Genetics·Paola Giusti-RodríguezFei Zou
Feb 6, 2020·Molecular Psychiatry·Nadine C van der BurgP Roberto Bakker
Oct 14, 2008·Experimental Biology and Medicine·Meeta PatnaikCarol R Reed
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Samer AlabedAbdullah Rifai
Jun 3, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Eva J BrandlDaniel J Müller

Related Concepts

Alleles
Dyskinesia, Medication-Induced
Glycine, Monopotasssium Salt
Genetic Polymorphism
Schizophreniform Disorders
Retrospective Studies
Serine
Antipsychotic Effect
Meta Analysis (Statistical Procedure)
Chi-Square Distribution

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here